181 related articles for article (PubMed ID: 28027413)
1. Omega 3: a novel treatment agent in oral submucous fibrosis: a pilot study.
Raizada MK; Sable DM; Chowdhery A; Chavan MS; Rajpurohit LS
J Oral Pathol Med; 2017 Jul; 46(6):439-442. PubMed ID: 28027413
[TBL] [Abstract][Full Text] [Related]
2. Clinical Assessment of Efficacy of Omega 3 in Oral Submucous Fibrosis Patients - A Randomized Controlled Trial.
Raizada MK; Sable DM
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1185-1192. PubMed ID: 35485674
[TBL] [Abstract][Full Text] [Related]
3. A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis.
Alora Veedu R; Balan A; Sankar S P
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):588-593.e1. PubMed ID: 26337213
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Curcumin in Combination with Intralesional Dexamethasone with Hyaluronidase in the Treatment of Oral Submucous Fibrosis: A Randomized Controlled Trial.
Adhikari S; Rimal J; Maharjan IK; Shrestha A
Asian Pac J Cancer Prev; 2022 Sep; 23(9):3125-3132. PubMed ID: 36172675
[TBL] [Abstract][Full Text] [Related]
5. In vivo autofluorescence characteristics of pre- and post-treated oral submucous fibrosis: a pilot study.
Vedeswari CP; Jayachandran S; Ganesan S
Indian J Dent Res; 2009; 20(3):261-7. PubMed ID: 19884705
[TBL] [Abstract][Full Text] [Related]
6. Intralesional corticosteroids as a treatment for restricted mouth opening in oral submucous fibrosis.
Tilakaratne WM; Ekanayaka RP; Herath M; Jayasinghe RD; Sitheeque M; Amarasinghe H
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):224-31. PubMed ID: 27422421
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline - A Novel Adjunct in the Management of Patients with Oral Submucous Fibrosis in Terai Population of Nepal: A Prospective Case Control Study.
Wazir SS; Srivastava R
Mymensingh Med J; 2022 Oct; 31(4):1170-1178. PubMed ID: 36189568
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of efficacy of aloe vera in the treatment of oral submucous fibrosis - a clinical study.
Anuradha A; Patil B; Asha VR
J Oral Pathol Med; 2017 Jan; 46(1):50-55. PubMed ID: 27314762
[TBL] [Abstract][Full Text] [Related]
9. Rebamipide to Manage Stomatopyrosis in Oral Submucous Fibrosis.
Baptist J; Shakya S; Ongole R
J Contemp Dent Pract; 2016 Dec; 17(12):1009-1012. PubMed ID: 27965488
[TBL] [Abstract][Full Text] [Related]
10. Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis.
Bhadage CJ; Umarji HR; Shah K; Välimaa H
Clin Oral Investig; 2013 Jun; 17(5):1375-82. PubMed ID: 22893038
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of spirulina as an antioxidant adjuvant to corticosteroid injection in management of oral submucous fibrosis.
Shetty P; Shenai P; Chatra L; Rao PK
Indian J Dent Res; 2013; 24(3):347-50. PubMed ID: 24025883
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases.
Lai DR; Chen HR; Lin LM; Huang YL; Tsai CC
J Oral Pathol Med; 1995 Oct; 24(9):402-6. PubMed ID: 8537913
[TBL] [Abstract][Full Text] [Related]
13. Black Turmeric and Aloe Vera in the Management of Oral Submucous Fibrosis: A Prospective Clinical Study.
Bohra A; Maheswari TNU; Harsh A; Garg A
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3941-3947. PubMed ID: 34967575
[TBL] [Abstract][Full Text] [Related]
14. Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: A randomized controlled trial.
Piyush P; Mahajan A; Singh K; Ghosh S; Gupta S
Oral Dis; 2019 Jan; 25(1):73-79. PubMed ID: 30059188
[TBL] [Abstract][Full Text] [Related]
15. A Comparative Study to Evaluate the Efficacy of Curcumin Lozenges (TurmNova
Srivastava R; Kundu A; Pradhan D; Jyoti B; Chokotiya H; Parashar P
J Contemp Dent Pract; 2021 Jul; 22(7):751-755. PubMed ID: 34615779
[TBL] [Abstract][Full Text] [Related]
16. Oral submucous fibrosis--treatment with hyalase.
Kakar PK; Puri RK; Venkatachalam VP
J Laryngol Otol; 1985 Jan; 99(1):57-9. PubMed ID: 3968475
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis.
Jiang XW; Zhang Y; Yang SK; Zhang H; Lu K; Sun GL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Mar; 115(3):339-44. PubMed ID: 23260769
[TBL] [Abstract][Full Text] [Related]
18. Comparison of curcumin with intralesional steroid injections in Oral Submucous Fibrosis - A randomized, open-label interventional study.
Yadav M; Aravinda K; Saxena VS; Srinivas K; Ratnakar P; Gupta J; Sachdev AS; Shivhare P
J Oral Biol Craniofac Res; 2014; 4(3):169-73. PubMed ID: 25737939
[TBL] [Abstract][Full Text] [Related]
19. Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature.
Auluck A; Rosin MP; Zhang L; Sumanth KN
J Can Dent Assoc; 2008 Oct; 74(8):735-40. PubMed ID: 18845065
[TBL] [Abstract][Full Text] [Related]
20. Allicin as a possible adjunctive therapeutic drug for stage II oral submucous fibrosis: a preliminary clinical trial in a Chinese cohort.
Jiang X; Zhang Y; Li F; Zhu Y; Chen Y; Yang S; Sun G
Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1540-6. PubMed ID: 26165773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
